RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 82 filers reported holding RECRO PHARMA INC in Q2 2019. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $126,000 | +9.6% | 11,353 | 0.0% | 0.23% | +34.1% |
| Q2 2019 | $115,000 | +71.6% | 11,353 | 0.0% | 0.17% | +86.8% |
| Q1 2019 | $67,000 | -17.3% | 11,353 | 0.0% | 0.09% | -48.9% |
| Q4 2018 | $81,000 | 0.0% | 11,353 | 0.0% | 0.18% | -7.8% |
| Q3 2018 | $81,000 | +28.6% | 11,353 | -10.0% | 0.19% | +40.9% |
| Q2 2018 | $63,000 | -54.7% | 12,615 | 0.0% | 0.14% | -49.8% |
| Q1 2018 | $139,000 | -40.3% | 12,615 | -50.0% | 0.27% | +35.1% |
| Q4 2017 | $233,000 | +2.6% | 25,231 | 0.0% | 0.20% | -1.0% |
| Q3 2017 | $227,000 | +28.2% | 25,231 | 0.0% | 0.20% | +25.9% |
| Q2 2017 | $177,000 | -59.9% | 25,231 | -50.0% | 0.16% | -50.5% |
| Q1 2017 | $441,000 | +37.0% | 50,463 | +26.2% | 0.33% | +27.2% |
| Q4 2016 | $322,000 | – | 40,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |